Top of page

IP & Commercial Transactions

Practice

Filters

Horizon Pharma Follow-On Offering

Davis Polk advised the underwriters in connection with the $345 million public offering of ordinary shares of Horizon Pharma…

FMC completes spinoff of Livent

Davis Polk advised FMC Corporation in connection with the spinoff of its 123,000,000 shares of common stock of Livent…
Back to top